Nagarro SE | WebDisclosure

PRESS RELEASE

published on 11/14/2025 at 07:06, 5 months 25 days ago

EQS-Adhoc: Management Board of Nagarro SE resolves on reduction of nominal share capital through redemption of treasury shares and on new share buyback program with a volume of up to 20 million euros
Nagarro SE's Management Board reduces nominal share capital by redeeming treasury shares and initiates a new share buyback program worth up to 20 million euros. Details provided on the stock exchange acquisition process

Share Buyback Treasury Shares Nagarro SE Nominal Share Capital Stock Exchange Acquisition
BRIEF

published on 08/14/2025 at 09:06, 8 months 26 days ago

Nagarro SE annonce une croissance modeste malgré les difficultés monétaires

EBITDA Ajusté Croissance Des Revenus Résultats Du Deuxième Trimestre 2025 Impact Des Devises Finances Nagarro
BRIEF

published on 08/14/2025 at 09:06, 8 months 26 days ago

Nagarro SE Reports Modest Growth Amid Currency Challenges

Adjusted EBITDA Revenue Growth Currency Impact Q2 2025 Results Nagarro Financials
PRESS RELEASE

published on 08/14/2025 at 09:01, 8 months 26 days ago

Nagarro releases unaudited Q2 2025 results, posts 4.7% YoY revenue growth in constant currency and 14.2% increase in gross profit despite global macroeconomic challenges
Nagarro releases unaudited Q2 2025 results, showing 4.7% YoY revenue growth in constant currency and 14.2% rise in gross profit despite global challenges

Financial Results Revenue Growth Gross Profit Nagarro Q2 2025
BRIEF

published on 05/15/2025 at 08:25, 11 months 25 days ago

Nagarro SE publie ses résultats financiers pour l'exercice 2024 et le premier trimestre 2025

Croissance Des Revenus Proposition De Dividende Résultats Financiers 2024 Résultats De Nagarro Données Du Premier Trimestre 2025
BRIEF

published on 05/15/2025 at 08:25, 11 months 25 days ago

Nagarro SE Reports FY 2024 and Q1 2025 Financial Results

Revenue Growth Dividend Proposal 2024 Financials Nagarro Results 2025 Q1 Data
PRESS RELEASE

published on 05/15/2025 at 08:20, 11 months 25 days ago

Nagarro releases audited FY 2024 and unaudited Q1 2025 results, confirms existing guidance for 2025
Nagarro releases audited FY 2024 and unaudited Q1 2025 results, maintaining guidance for 2025. Revenue growth and dividend proposal highlighted

Financial Results Revenue Growth Dividend Proposal Nagarro 2025 Guidance
BRIEF

published on 04/29/2025 at 08:19, 1 year ago

Nagarro Reports 6.6% Revenue Growth for FY 2024

Adjusted EBITDA Revenue Growth Gross Margin Cash Balance Employee Count
BRIEF

published on 04/29/2025 at 08:19, 1 year ago

Nagarro annonce une croissance de son chiffre d'affaires de 6,6 % pour l'exercice 2024

Marge Brute EBITDA Ajusté Croissance Des Revenus Solde De Trésorerie Nombre D'employés
PRESS RELEASE

published on 04/29/2025 at 08:14, 1 year ago

Nagarro announces preliminary numbers for FY 2024: revenue grows to €972 million, Adjusted EBITDA margin to 15.1%
Nagarro reports preliminary FY 2024 results: Revenue reaches €972 million with 15.1% Adjusted EBITDA margin. Company plans to release full annual report on May 15, 2025

Financial Results Revenue Growth EBITDA Margin Nagarro FY 2024

Published on 05/09/2026 at 01:55, 16 hours 24 minutes ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 16 hours 39 minutes ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 16 hours 49 minutes ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 18 hours 19 minutes ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 19 hours 18 minutes ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

Published on 05/08/2026 at 20:38, 21 hours 40 minutes ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 23 hours 6 minutes ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 23 hours 16 minutes ago

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/08/2026 at 18:29, 23 hours 49 minutes ago

Designated Person Notification
Published on 05/08/2026 at 18:29, 23 hours 49 minutes ago

Designated Person Notification

View all EQS

Published on 05/07/2026 at 19:15, 1 day 23 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 23 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 23 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 23 hours ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 23 hours ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE

News